Arazlo
tazarotene
- Strength
- .45 mg/g
- Form
- Lotion
- Class
- Retinoid
Bausch Health US, LLC
Listed by Cosette Pharmaceuticals, Inc.
| Dosage form | Cream |
|---|---|
| Route | Topical |
| Drug class | Retinoid |
| Approval route | ANDA — approved generic |
| NDC code | 0713-0765 |
| FDA application | ANDA208662 |
| RxNorm concept | 313200 |
| Package sizes listed | 2 |
| Marketed since | March 2025 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
tazarotene
Bausch Health US, LLC
tazarotene
Mayne Pharma
Mayne Pharma
Cosette Pharmaceuticals, Inc.
Cosette Pharmaceuticals, Inc.
Solaris Pharma Corporation
Padagis Israel Pharmaceuticals Ltd
Padagis Israel Pharmaceuticals Ltd
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.